Concerns Mount as More States Adopt Biomarker Laws
Health Payer SpecialistHealth Payer Specialist
As Chair of Baker Botts' Life Sciences IP Practice group, Steve advises clients on a wide range of biotechnology-related intellectual property issues. Whether evaluating third party patents ahead of product launches for a multinational biopharma enterprise, developing patent filing strategies around new therapeutic approaches for a leading cancer research institution, or advocating for an industry-transforming sequencing company before the Patent Trial and Appeal Board, Steve's value-add is providing technically-informed and commercially-relevant legal advice that the scientists, the in-house legal team, and the C-suite can all understand.
Before attending law school, Steve performed his graduate school research on the protein-nucleic acid interactions underlying pre-messenger RNA splicing. Prior to graduate school, he was an assistant process development scientist at a large pharmaceutical company working on the production of recombinant blood clotting factors.
Strategic Patent Counseling and IP Diligence
PTAB Proceedings
Patent Litigation & Amicus Filings
Listed in Patent Litigation, Who's Who Legal: Life Sciences, 2016
Health Payer Specialist
Law360
Pharmaceutical Executive Online
Pharma Letter, The
Bloomberg Law
Law360
Bloomberg Law
Law360
Bloomberg Law
Bloomberg Law
Law360
Intellectual Property Report
Intellectual Property Update
Intellectual Property Update
Baker Botts and Salem Partners will be hosting a private reception during the J.P.Morgan Healthcare Conference to be held at Jasper's Corner Tap and Kitchen on Monday January 13, 2020.